GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $71,180,000 | +67.5% | 1,635,183 | +67.6% | 0.19% | +128.9% |
| Q1 2022 | $42,498,000 | +3.9% | 975,627 | +5.2% | 0.08% | +5.1% |
| Q4 2021 | $40,884,000 | +17.8% | 927,058 | +2.1% | 0.08% | +12.9% |
| Q3 2021 | $34,704,000 | -3.6% | 908,038 | +0.4% | 0.07% | -4.1% |
| Q2 2021 | $36,001,000 | +12.5% | 904,108 | +0.8% | 0.07% | +4.3% |
| Q1 2021 | $32,011,000 | -0.7% | 896,905 | +2.4% | 0.07% | -6.7% |
| Q4 2020 | $32,228,000 | -5.8% | 875,750 | -3.7% | 0.08% | -17.6% |
| Q3 2020 | $34,226,000 | -9.2% | 909,310 | -1.7% | 0.09% | -19.5% |
| Q2 2020 | $37,709,000 | +10861.9% | 925,130 | +10089.8% | 0.11% | +11200.0% |
| Q1 2020 | $344,000 | -85.4% | 9,079 | -83.5% | 0.00% | -85.7% |
| Q3 2019 | $2,349,000 | +0.7% | 55,038 | -5.6% | 0.01% | 0.0% |
| Q2 2019 | $2,333,000 | +41.1% | 58,298 | +47.4% | 0.01% | +40.0% |
| Q1 2019 | $1,653,000 | -20.6% | 39,558 | -27.4% | 0.01% | -37.5% |
| Q4 2018 | $2,083,000 | -96.1% | 54,518 | -95.9% | 0.01% | -95.2% |
| Q3 2018 | $52,960,000 | +0.3% | 1,318,402 | +0.7% | 0.17% | -3.5% |
| Q2 2018 | $52,790,000 | -1.2% | 1,309,592 | -4.2% | 0.17% | -5.0% |
| Q1 2018 | $53,426,000 | +3.2% | 1,367,440 | -6.3% | 0.18% | +4.6% |
| Q4 2017 | $51,753,000 | -15.4% | 1,459,065 | -3.2% | 0.17% | -19.9% |
| Q3 2017 | $61,187,000 | -4.9% | 1,507,089 | +1.0% | 0.22% | -19.1% |
| Q2 2017 | $64,360,000 | +11.2% | 1,492,601 | +8.7% | 0.27% | +6.4% |
| Q1 2017 | $57,884,000 | +93261.3% | 1,373,066 | +87023.5% | 0.25% | – |
| Q4 2016 | $62,000 | -44.1% | 1,576 | -38.8% | 0.00% | -100.0% |
| Q3 2016 | $111,000 | -3.5% | 2,576 | -2.8% | 0.00% | 0.0% |
| Q2 2016 | $115,000 | +8.5% | 2,651 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $106,000 | +2.9% | 2,555 | 0.0% | 0.00% | – |
| Q4 2015 | $103,000 | -2.8% | 2,555 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $106,000 | -12.4% | 2,555 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $121,000 | +7.1% | 2,555 | -1.9% | 0.00% | 0.0% |
| Q4 2014 | $113,000 | +54.8% | 2,605 | +62.3% | 0.00% | – |
| Q3 2014 | $73,000 | -72.5% | 1,605 | -69.7% | 0.00% | -100.0% |
| Q2 2013 | $265,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |